← Leaderboards
Philip E. Cryer
Washington University
$4,377,949
Attributed
$4,377,949
Total exposure
17
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $552.1K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$4,377,949 · 17
By mechanism
R37$3,563,071 · 1
P60$455,062 · 1
M01$359,816 · 15
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Gay R Holstein$10,818,300
- H. Mark Johnston$7,646,500
- Neil H. White$12,778,445
- Robert E Schmidt$4,976,339
- Samuel Klein$33,055,933
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHypoglycemiaGlucose TransportGlucose Clamp TechniqueInsulin Dependent Diabetes MellitusHyperinsulinismDiabetes MellitusGlucose MetabolismHyperglycemiaBlood GlucoseAutonomic DisorderGlucagonBrain MetabolismHormone Regulation /Control MechanismNorepinephrineInsulinBlood Brain BarrierNeuroendocrine SystemPositron Emission TomographyHealth Science ResearchHealth Care Personnel EducationHealth Services Research TagGlucose Plasma Concentration
Grant awards (52)
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$355,425
R37 · FY2009 · DK · contact PI
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$355,425
R37 · FY2008 · DK · contact PI
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$362,679
R37 · FY2007 · DK · contact PI
AIM 9: TYPE 1 DIABETES: A MODEL OF ISOLATED ALPHA-CELL GLUCAGON SECRETION$18,029
M01 · FY2007 · RR · contact PI
AIM 7: THE PREVENTION OF NOCTURNAL HYPOGLYCEMIA IN TYPE 1 DIABETES$4,743
M01 · FY2007 · RR · contact PI
AIM 8: MAINTENANCE OF THE POSTABSORPTIVE PLASMA GLUCOSE CONCENTRATION$3,794
M01 · FY2007 · RR · contact PI
AAMP AIM 6: MAPPING THE BRAIN GLUCOSE SENSOR$3,659
M01 · FY2007 · RR · contact PI
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$373,511
R37 · FY2006 · DK · contact PI
AIM 7: THE PREVENTION OF NOCTURNAL HYPOGLYCEMIA IN TYPE 1 DIABETES$44,564
M01 · FY2006 · RR · contact PI
AIM 8: MAINTENANCE OF THE POSTABSORPTIVE PLASMA GLUCOSE CONCENTRATION$34,151
M01 · FY2006 · RR · contact PI
AAMP AIM 6: MAPPING THE BRAIN GLUCOSE SENSOR$14,160
M01 · FY2006 · RR · contact PI
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$382,500
R37 · FY2005 · DK
AIM 7: THE PREVENTION OF NOCTURNAL HYPOGLYCEMIA IN TYPE 1 DIABETES$106,801
M01 · FY2005 · RR
AAMP AIM 6: MAPPING THE BRAIN GLUCOSE SENSOR$29,575
M01 · FY2005 · RR
AIM 8: MAINTENANCE OF THE POSTABSORPTIVE PLASMA GLUCOSE CONCENTRATION$23,004
M01 · FY2005 · RR
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY: AIM 5$10,269
M01 · FY2005 · RR
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$346,500
R37 · FY2004 · DK
Adrenergic Mechanisms in Metabolic Pathophysiology: Aim 5$29,382
M01 · FY2004 · RR
Aim 7: The Prevention of Nocturnal Hypoglycemia in Type 1 Diabetes$27,785
M01 · FY2004 · RR
AAMP Aim 6: Mapping the Brain Glucose Sensor$9,900
M01 · FY2004 · RR
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$346,500
R37 · FY2003 · DK
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$346,500
R37 · FY2002 · DK
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY--CORTISOL IN AUTONOMIC FAILURE$0
M01 · FY2002 · RR
PATHOPHYSIOLOGY AND MANAGEMENT OF PITUITARY TUMORS$0
M01 · FY2002 · RR
MECHANISMS OF ANTECEDENT HYPOGLYCEMIA ON RESPONSES TO HYPOGLYCEMIA$0
M01 · FY2002 · RR
HYPOGLYCEMIA ASSOCIATED AUTONOMIC FAILURE IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2002 · RR
CONTINUOUS GLUCOSE MONITORING SYSTEM$0
M01 · FY2002 · RR
CONTINUOUS GLUCOSE MONITORING SYSTEM$0
M01 · FY2002 · RR
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY--GLUCAGON IN GLUCOSE CONTERREG$0
M01 · FY2002 · RR
CORE--CLINICAL RESEARCH FACILITY AND DIABETES REGISTRY$0
P60 · FY2002 · DK
CORE--CLINICAL RESEARCH FACILITY AND DIABETES REGISTRY$0
P60 · FY2002 · DK
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$346,500
R37 · FY2001 · DK
CORE--CLINICAL RESEARCH FACILITY AND DIABETES REGISTRY$211,312
P60 · FY2001 · DK
CORE--CLINICAL RESEARCH FACILITY AND DIABETES REGISTRY$0
P60 · FY2001 · DK
CORE--CLINICAL RESEARCH FACILITY AND DIABETES REGISTRY$0
P60 · FY2001 · DK
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY--GLUCAGON IN GLUCOSE CONTERREG$0
M01 · FY2001 · RR
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY--CORTISOL IN AUTONOMIC FAILURE$0
M01 · FY2001 · RR
CONTINUOUS GLUCOSE MONITORING SYSTEM$0
M01 · FY2001 · RR
CONTINUOUS GLUCOSE MONITORING SYSTEM$0
M01 · FY2001 · RR
HYPOGLYCEMIA ASSOCIATED AUTONOMIC FAILURE IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2001 · RR
PATHOPHYSIOLOGY AND MANAGEMENT OF PITUITARY TUMORS$0
M01 · FY2001 · RR
MECHANISMS OF ANTECEDENT HYPOGLYCEMIA ON RESPONSES TO HYPOGLYCEMIA$0
M01 · FY2001 · RR
CORE--CLINICAL RESEARCH FACILITY AND DIABETES REGISTRY$0
P60 · FY2001 · DK
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY$347,531
R37 · FY2000 · DK
CORE--CLINICAL RESEARCH FACILITY AND DIABETES REGISTRY$243,750
P60 · FY2000 · DK
MECHANISMS OF ANTECEDENT HYPOGLYCEMIA ON RESPONSES TO HYPOGLYCEMIA$0
M01 · FY2000 · RR
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY--GLUCAGON IN GLUCOSE CONTERREG$0
M01 · FY2000 · RR
ADRENERGIC MECHANISMS IN METABOLIC PATHOPHYSIOLOGY--CORTISOL IN AUTONOMIC FAILURE$0
M01 · FY2000 · RR
CONTINUOUS GLUCOSE MONITORING SYSTEM$0
M01 · FY2000 · RR
CONTINUOUS GLUCOSE MONITORING SYSTEM$0
M01 · FY2000 · RR
HYPOGLYCEMIA ASSOCIATED AUTONOMIC FAILURE IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2000 · RR
PATHOPHYSIOLOGY AND MANAGEMENT OF PITUITARY TUMORS$0
M01 · FY2000 · RR